Sayenza Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $760K

  • Investors
  • 10

Sayenza Bio General Information

Description

Operator of a biotechnology platform intended to democratize access to regenerative medicine by harnessing the body's fat to improve patient outcomes. The company offers an automated, multifunctional device that rapidly processes liposuction fat into optimized fat grafts and stem cell therapeutics, enabling surgeons and clinicians to deliver point-of-care aesthetic and regenerative treatments, improving clinical efficiency and outcomes.

Contact Information

Website
www.sayenza.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5270 California Avenue
  • Suite 100
  • Irvine, CA 92617-3231
  • United States
+1 (615)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 5270 California Avenue
  • Suite 100
  • Irvine, CA 92617-3231
  • United States
+1 (615)

Sayenza Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sayenza Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Seed Round 04-Dec-2024 $760K Completed Product Development
10. Accelerator/Incubator 28-May-2024 Completed Product Development
9. Accelerator/Incubator 01-Oct-2023 Completed Product Development
8. Grant 01-Jun-2023 Completed Clinical Trials - General
7. Seed Round 28-Mar-2023 Completed Clinical Trials - General
6. Accelerator/Incubator 01-Jan-2023 Completed Startup
5. Accelerator/Incubator 01-Jan-2023 Completed Startup
4. Grant 08-Apr-2022 Completed Startup
3. Accelerator/Incubator 01-Apr-2021 $15K $15K Completed Startup
2. Accelerator/Incubator Completed Product Development
To view Sayenza Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sayenza Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology platform intended to democratize access to regenerative medicine by harnessing the body's fa
Biotechnology
Irvine, CA
7 As of 2026

Louisville, CO
 

Brandon, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sayenza Bio Competitors (8)

One of Sayenza Bio’s 8 competitors is GID BIO, a Venture Capital-Backed company based in Louisville, CO.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GID BIO Venture Capital-Backed Louisville, CO
Jointechlabs Venture Capital-Backed Brandon, FL
Lipogems Venture Capital-Backed Milan, Italy
Human Med Private Equity-Backed Schwerin, Germany
Synova Life Sciences Venture Capital-Backed Pasadena, CA
You’re viewing 5 of 8 competitors. Get the full list »

Sayenza Bio Patents

Sayenza Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4777607-A2 Methods and systems for processing lipoaspirate Pending 20-Jul-2023
WO-2025019868-A2 Methods and systems for processing lipoaspirate Inactive 20-Jul-2023
WO-2025019868-A3 Methods and systems for processing lipoaspirate Inactive 20-Jul-2023
EP-4687926-A2 Fluidic device for washing of lipoaspirate Pending 28-Mar-2023
US-20260284266-A1 Fluidic device for washing of lipoaspirate Pending 28-Mar-2023 A61L27/3691
To view Sayenza Bio’s complete patent history, request access »

Sayenza Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sayenza Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
California Life Sciences Accelerator/Incubator
National Science Foundation Innovation Corps Program Accelerator/Incubator Minority
McDermott Will & Schulte Corporation
friends x family Corporation Minority
Octane (California) Accelerator/Incubator
You’re viewing 5 of 10 investors. Get the full list »

Sayenza Bio FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process